跳至主要内容
临床试验/ACTRN12618001909213
ACTRN12618001909213尚未招募不适用

Evaluating the feasibility of a Co-designed Prehabilitation Program (Co-PreP) for patients with prostate cancer

Western Health0 个研究点目标入组 40 人开始时间: 2018年11月23日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Prostate cancer patients receiving treatment at either Western Health or Peter MacCallum Sunshine Radiotherapy Centre. Treatment modalities may include radiotherapy, brachy therapy, radical prostatectomy, chemotherapy and hormone replacement therapies.
  • Physically able to participate in an outpatient group exercise program as determined by their ability to ambulate independently with or without a gait aid.
  • Cognitively able to comprehend information disseminated during the education session.

排除标准

  • Patients who are flagged for active surveillance for their prostate cancer.
  • Patients who have pre-existing comorbidities hindering their ability to participate in an outpatient group exercise program: for example: unstable angina, stroke, severe musculoskeletal pain.
  • Prostate cancer patients who are in the terminal phase of their illness, as deemed by the treating specialist(s).
  • Prostate cancer patients who have pre-existing cognitive impairments or psychiatric history that will hinder their ability to participate.
  • Patients who have a waiting time of less than 2 weeks before commencement of treatment.

研究者

相似试验